Form 4/A for REGN Regeneron Pharmaceuticals
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-20 · accession 0001104659-21-109328 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2021-08-25 | 2021-08-20 | REGN | Fenimore Christopher R. | SVP Ctrl | F - Tax | $664.85 | -8,719 | 19.0K | -31% | -$5.80M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-20 | F | D | 8,719 | $664.85 | 19,020 | D | — | — | (F2) The amount of securities shown following the reported transaction gives effect to the other transactions reported by the Reporting Person in the Original Form 4. |